News Digital health hit hard by VC slump in 2023, says report There’s little doubt that financing for digital health companies remains in the doldrums.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
